NCT00519376View on ClinicalTrials.gov

A Study To Investigate The Effect Of Inhaling A Single Dose Of GW642444M In COPD Patients.

PHASE2CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

GW642444M

drug

DRUG

GW642444H

drug

DRUG

placebo

Trial Locations (4)

14050

GSK Investigational Site, Berlin

14057

GSK Investigational Site, Berlin

55131

GSK Investigational Site, Mainz

65187

GSK Investigational Site, Wiesbaden

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY